These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9477594)

  • 1. [Sex hormones and osteoporosis: a physiological perspective for prevention and therapy].
    da Silva JA; Porto A
    Acta Med Port; 1997 Oct; 10(10):689-95. PubMed ID: 9477594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans.
    Wimalawansa SJ
    Ann N Y Acad Sci; 2007 Nov; 1117():283-97. PubMed ID: 18056048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens in rheumatoid arthritis; the immune system and bone.
    Islander U; Jochems C; Lagerquist MK; Forsblad-d'Elia H; Carlsten H
    Mol Cell Endocrinol; 2011 Mar; 335(1):14-29. PubMed ID: 20685609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis].
    Ribot C; Tremollieres F; Pouilles JM
    Ann Med Interne (Paris); 2000 Oct; 151(6):490-6. PubMed ID: 11104929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse Romande; 2002 Aug; 122(8):377-81. PubMed ID: 12357730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of oestrogen deficiency on the skeleton and its prevention.
    Fogelman I
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():5-9. PubMed ID: 8916979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of osteoporosis in male hypogonadism].
    Tsukamoto T; Itoh N
    Clin Calcium; 2006 Mar; 16(3):481-5. PubMed ID: 16508132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
    Col NF; Bowlby LA; McGarry K
    Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60.
    Studd J
    Climacteric; 2009 Jun; 12(3):206-9. PubMed ID: 19437196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover].
    Ohnaka K; Takayanagi R
    Clin Calcium; 2009 Aug; 19(8):1118-24. PubMed ID: 19638695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen/androgen therapy on bone mineral density parameters.
    Notelovitz M
    J Reprod Med; 2001 Mar; 46(3 Suppl):325-31. PubMed ID: 11304880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Recent evidence of estrogen therapy for osteoporosis].
    Higuchi T; Mizunuma H
    Clin Calcium; 2008 Aug; 18(8):1141-6. PubMed ID: 18677052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis prevention and treatment.
    Sambrook PN; Eisman JA
    Med J Aust; 2000 Mar; 172(5):226-9. PubMed ID: 10776395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoporosis is prevented by physical activity, calcium and hormone supplementation].
    Piehl-Aulin K; Brahm H
    Lakartidningen; 1999 Jan; 96(3):210-4. PubMed ID: 10068323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.